BIO Protocol Secures $6.9 Million in Seed Funding on September 17, 2025

According to industry sources, BIO Protocol raised $6.9 million in its Seed funding round on September 17, 2025. The round was backed by leading investors including Maelstrom Capital, Mechanism Capital, Animoca Brands, Zee Prime Capital, Mirana Ventures, Foresight Ventures, Big Brain Holdings, and Panga Capital. With this latest financing, BIO Protocol’s cumulative funding has reached $17.86 million, underscoring strong market confidence in its growth prospects.BIO Protocol serves as a financial infrastructure layer designed for the decentralized science (DeSci) sector, aiming to accelerate the flow of capital and talent into on-chain scientific research. The protocol enables bio DAOs to raise funds through BIO Protocol’s auction contracts and allocate capital to research projects, intellectual property assets, and other biotech organizations. This innovative approach supports the democratization and transparency of scientific research.Since launch, BIO Protocol has achieved several key milestones. In January 2025, BIO was officially listed for trading and subsequently debuted on Binance and other major exchanges, receiving robust market liquidity support. In April 2025, the protocol released its upgraded V1 version, introducing a Launchpad feature that further enhances its ecosystem toolkit. In July, Coinbase added BIO Protocol to its asset roadmap, marking a significant endorsement of its development potential. The team also proposed a linear token unlock schedule, demonstrating a commitment to long-term project growth.As the migration of scientific research onto blockchain platforms accelerates, BIO Protocol is poised to play a pivotal role in bridging traditional science with blockchain technology and advancing the democratization of scientific innovation financing.